First Header Logo Second Header Logo

Connection

Haodong Xu to Immunohistochemistry

This is a "connection" page, showing publications Haodong Xu has written about Immunohistochemistry.
Connection Strength

2.729
  1. Woo JS, Reddy OL, Koo M, Xiong Y, Li F, Xu H. Application of Immunohistochemistry in the Diagnosis of Pulmonary and Pleural Neoplasms. Arch Pathol Lab Med. 2017 Sep; 141(9):1195-1213.
    View in: PubMed
    Score: 0.518
  2. Fishbein GA, Grimes BS, Xian RR, Lee JM, Barjaktarevic I, Xu H. Primary salivary duct carcinoma of the lung, mucin-rich variant. Hum Pathol. 2016 Jan; 47(1):150-6.
    View in: PubMed
    Score: 0.115
  3. Arcega R, Yong WH, Xu H. Malignant melanoma mimicking giant cell variant of glioblastoma multiforme: a case report and review of literature. Int J Clin Exp Pathol. 2015; 8(5):5929-33.
    View in: PubMed
    Score: 0.112
  4. Choy B, Findeis-Hosey JJ, Li F, McMahon LA, Yang Q, Xu H. High frequency of coexpression of maspin with p63 and p53 in squamous cell carcinoma but not in adenocarcinoma of the lung. Int J Clin Exp Pathol. 2013; 6(11):2542-7.
    View in: PubMed
    Score: 0.100
  5. Fan X, Liu B, Xu H, Yu B, Shi S, Zhang J, Wang X, Wang J, Lu Z, Ma H, Zhou X. Immunostaining with EGFR mutation-specific antibodies: a reliable screening method for lung adenocarcinomas harboring EGFR mutation in biopsy and resection samples. Hum Pathol. 2013 Aug; 44(8):1499-507.
    View in: PubMed
    Score: 0.096
  6. Xiong Y, Bai Y, Leong N, Laughlin TS, Rothberg PG, Xu H, Nong L, Zhao J, Dong Y, Li T. Immunohistochemical detection of mutations in the epidermal growth factor receptor gene in lung adenocarcinomas using mutation-specific antibodies. Diagn Pathol. 2013 Feb 18; 8:27.
    View in: PubMed
    Score: 0.096
  7. Denby KS, Briones AJ, Bourne PA, Spaulding BO, Lu D, Fischer-Colbrie R, Qu Z, Wang HL, Xu H. IMP3, NESP55, TTF-1 and CDX2 serve as an immunohistochemical panel in the distinction among small-cell carcinoma, gastrointestinal carcinoid, and pancreatic endocrine tumor metastasized to the liver. Appl Immunohistochem Mol Morphol. 2012 Dec; 20(6):573-9.
    View in: PubMed
    Score: 0.094
  8. Findeis-Hosey JJ, Xu H. Insulin-like growth factor II-messenger RNA-binding protein-3 and lung cancer. Biotech Histochem. 2012 Jan; 87(1):24-9.
    View in: PubMed
    Score: 0.086
  9. Ye J, Hameed O, Findeis-Hosey JJ, Fan L, Li F, McMahon LA, Yang Q, Wang HL, Xu H. Diagnostic utility of PAX8, TTF-1 and napsin A for discriminating metastatic carcinoma from primary adenocarcinoma of the lung. Biotech Histochem. 2012 Jan; 87(1):30-4.
    View in: PubMed
    Score: 0.086
  10. Mentrikoski MJ, Zhao C, Zhang J, Wang HL, McMahon LA, Yang Q, Li F, Xu H. Metastatic endometrial stromal sarcoma of the lung: importance of immunohistochemical staining, clinical history and imaging studies. Biotech Histochem. 2012 Jan; 87(1):35-9.
    View in: PubMed
    Score: 0.086
  11. Ye J, Findeis-Hosey JJ, Yang Q, McMahon LA, Yao JL, Li F, Xu H. Combination of napsin A and TTF-1 immunohistochemistry helps in differentiating primary lung adenocarcinoma from metastatic carcinoma in the lung. Appl Immunohistochem Mol Morphol. 2011 Jul; 19(4):313-7.
    View in: PubMed
    Score: 0.086
  12. Findeis-Hosey JJ, Huang J, Li F, Yang Q, McMahon LA, Xu H. High-grade neuroendocrine carcinomas of the lung highly express enhancer of zeste homolog 2, but carcinoids do not. Hum Pathol. 2011 Jun; 42(6):867-72.
    View in: PubMed
    Score: 0.083
  13. Hu Y, Yang Q, McMahon LA, Wang HL, Xu H. Value of D2-40 in the differential diagnosis of pleural neoplasms with emphasis on its positivity in solitary fibrous tumor. Appl Immunohistochem Mol Morphol. 2010 Oct; 18(5):411-3.
    View in: PubMed
    Score: 0.081
  14. Johnson MD, Vito F, Xu H. MUC16 expression and risk of adenocarcinoma metastases to peritoneum, pleura, leptomeninges, and brain. Appl Immunohistochem Mol Morphol. 2010 May; 18(3):250-3.
    View in: PubMed
    Score: 0.079
  15. Findeis-Hosey JJ, Yang Q, Spaulding BO, Wang HL, Xu H. IMP3 expression is correlated with histologic grade of lung adenocarcinoma. Hum Pathol. 2010 Apr; 41(4):477-84.
    View in: PubMed
    Score: 0.077
  16. Hu Y, Mahar TJ, Hicks DG, Raymond D, Jones C, Wandtke JC, Powers JM, Xu H. Malignant solitary fibrous tumor: report of 3 cases with unusual features. Appl Immunohistochem Mol Morphol. 2009 Oct; 17(5):451-7.
    View in: PubMed
    Score: 0.076
  17. Mentrikoski MJ, Ma L, Pryor JG, McMahon LA, Yang Q, Spaulding BO, Scott GA, Wang HL, Xu H. Diagnostic utility of IMP3 in segregating metastatic melanoma from benign nevi in lymph nodes. Mod Pathol. 2009 Dec; 22(12):1582-7.
    View in: PubMed
    Score: 0.075
  18. Fallone E, Bourne PA, Watson TJ, Ghossein RA, Travis WD, Xu H. Ectopic (mediastinal) parathyroid adenoma with prominent lymphocytic infiltration. Appl Immunohistochem Mol Morphol. 2009 Jan; 17(1):82-4.
    View in: PubMed
    Score: 0.072
  19. Miyamoto H, Jones CE, Raymond DP, Wandtke JC, Strang JG, Bourne PA, Bonfiglio TA, Xu H. Pulmonary metastases from uterine neoplasms after long tumour-free interval: four cases and review of the literature. Pathology. 2009; 41(3):234-41.
    View in: PubMed
    Score: 0.072
  20. Pryor JG, Simon RA, Bourne PA, Spaulding BO, Scott GA, Xu H. Merkel cell carcinoma expresses K homology domain-containing protein overexpressed in cancer similar to other high-grade neuroendocrine carcinomas. Hum Pathol. 2009 Feb; 40(2):238-43.
    View in: PubMed
    Score: 0.071
  21. Wagner D, Bourne PA, Yang Q, Goldman BI, Lewis JS, Xu H. Unusual features of malignant pleural mesothelioma metastatic to the mediastinal lymph nodes. Appl Immunohistochem Mol Morphol. 2008 May; 16(3):301-7.
    View in: PubMed
    Score: 0.069
  22. Hanley KZ, Facik MS, Bourne PA, Yang Q, Spaulding BO, Bonfiglio TA, Xu H. Utility of anti-L523S antibody in the diagnosis of benign and malignant serous effusions. Cancer. 2008 Feb 25; 114(1):49-56.
    View in: PubMed
    Score: 0.068
  23. Pryor JG, Bourne PA, Yang Q, Spaulding BO, Scott GA, Xu H. IMP-3 is a novel progression marker in malignant melanoma. Mod Pathol. 2008 Apr; 21(4):431-7.
    View in: PubMed
    Score: 0.067
  24. LaPoint RJ, Bourne PA, Wang HL, Xu H. Coexpression of c-kit and bcl-2 in small cell carcinoma and large cell neuroendocrine carcinoma of the lung. Appl Immunohistochem Mol Morphol. 2007 Dec; 15(4):401-6.
    View in: PubMed
    Score: 0.067
  25. Xu H, Bourne PA, Spaulding BO, Wang HL. High-grade neuroendocrine carcinomas of the lung express K homology domain containing protein overexpressed in cancer but carcinoid tumors do not. Hum Pathol. 2007 Apr; 38(4):555-63.
    View in: PubMed
    Score: 0.063
  26. Ye B, Cappel J, Findeis-Hosey J, McMahon L, Yang Q, Xiao GQ, Xu H, Li F. hASH1 is a specific immunohistochemical marker for lung neuroendocrine tumors. Hum Pathol. 2016 Feb; 48:142-7.
    View in: PubMed
    Score: 0.029
  27. Chan OT, Chiles L, Levy M, Zhai J, Yerian LM, Xu H, Xiao SY, Soffer EE, Conklin JL, Dhall D, Kahn ME, Balzer BL, Amin MB, Wang HL. Smoothelin expression in the gastrointestinal tract: implication in colonic inertia. Appl Immunohistochem Mol Morphol. 2013 Oct; 21(5):452-9.
    View in: PubMed
    Score: 0.025
  28. Desouki MM, Lioyd J, Xu H, Cao D, Barner R, Zhao C. CDX2 may be a useful marker to distinguish primary ovarian carcinoid from gastrointestinal metastatic carcinoids to the ovary. Hum Pathol. 2013 Nov; 44(11):2536-41.
    View in: PubMed
    Score: 0.025
  29. Schmidt MT, Himmelfarb EA, Shafi H, Lin F, Xu H, Wang HL. Use of IMP3, S100P, and pVHL immunopanel to aid in the interpretation of bile duct biopsies with atypical histology or suspicious for malignancy. Appl Immunohistochem Mol Morphol. 2012 Oct; 20(5):478-87.
    View in: PubMed
    Score: 0.023
  30. Ye B, Ge Y, Perens G, Hong L, Xu H, Fishbein MC, Li F. Canonical Wnt/ß-catenin signaling in epicardial fibrosis of failed pediatric heart allografts with diastolic dysfunction. Cardiovasc Pathol. 2013; 22(1):54-7.
    View in: PubMed
    Score: 0.023
  31. Li F, Ye B, Hong L, Xu H, Fishbein MC. Epigenetic modifications of histone h4 in lung neuroendocrine tumors. Appl Immunohistochem Mol Morphol. 2011 Oct; 19(5):389-94.
    View in: PubMed
    Score: 0.022
  32. Yu L, Xu H, Wasco MJ, Bourne PA, Ma L. IMP-3 expression in melanocytic lesions. J Cutan Pathol. 2010 Mar; 37(3):316-22.
    View in: PubMed
    Score: 0.019
  33. Köbel M, Xu H, Bourne PA, Spaulding BO, Shih IeM, Mao TL, Soslow RA, Ewanowich CA, Kalloger SE, Mehl E, Lee CH, Huntsman D, Gilks CB. IGF2BP3 (IMP3) expression is a marker of unfavorable prognosis in ovarian carcinoma of clear cell subtype. Mod Pathol. 2009 Mar; 22(3):469-75.
    View in: PubMed
    Score: 0.018
  34. Simon RA, di Sant'Agnese PA, Huang LS, Xu H, Yao JL, Yang Q, Liang S, Liu J, Yu R, Cheng L, Oh WK, Palapattu GS, Wei J, Huang J. CD44 expression is a feature of prostatic small cell carcinoma and distinguishes it from its mimickers. Hum Pathol. 2009 Feb; 40(2):252-8.
    View in: PubMed
    Score: 0.018
  35. Li L, Xu H, Spaulding BO, Cheng L, Simon R, Yao JL, di Sant'Agnese PA, Bourne PA, Huang J. Expression of RNA-binding protein IMP3 (KOC) in benign urothelium and urothelial tumors. Hum Pathol. 2008 Aug; 39(8):1205-11.
    View in: PubMed
    Score: 0.017
  36. Hameed O, Xu H, Saddeghi S, Maluf H. Hepatoid carcinoma of the pancreas: a case report and literature review of a heterogeneous group of tumors. Am J Surg Pathol. 2007 Jan; 31(1):146-52.
    View in: PubMed
    Score: 0.016
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.